Table 1 Population characteristics at time of ECMO implantation

n

89

Age, years

54 [44, 60]

Sex

 Male

63 (71)

 Female

26 (29)

BMI, kg/m²

26.8 [23.5, 30.8]

ECMO configuration

 V-V

33 (37)

 V-A

56 (63)

Main diagnosis

 Sepsis

44 (49)

 Cardiogenic shock

51 (57)

 ARDS

38 (43)

Comorbidities

 Obesity

25 (28)

 Cardiovascular disease

42 (47)

 COPD

5 (6)

 Chronic kidney disease

10 (11)

 Diabetes mellitus

20 (22)

 Cancer

9 (10)

Mechanical ventilation

76 (85)

Renal replacement therapy

9 (10)

Norepinephrine, µg/min

12 [4, 35]

PEEP, mbar

7 [5, 12]

PaO₂/FiO₂ at cannulation, mmHg

89 [62, 149]

Bilirubin, µmol/L

10 [6, 16]

LDH, U/L

672 [435, 1130]

Platelets, G/L

210 [123, 282]

Fibrinogen, g/L

4.3 [2.2, 6.4]

d-Dimer, mg/L

3.5 [2.2, 5.1]

pH

7.27 [7.14, 7.38]

PaCO₂, kPa

6.1 [4.8, 9.0]

PaO₂, kPa

10.3 [8.4, 13.8]

Hemoglobin, g/L

104 [87, 124]

SaO₂, %

93 [89, 97]

FO₂Hb, %

90 [88, 95]

FCOHb, %

0.9 [0.6, 1.3]

FMetHb, %

0.9 [0.7, 1.3]

Lactate, mmol/L

1.9 [1.3, 5.0]